Private
Moderna, Inc. announced this week that it has finished its submission to the United States Food and Drug Administration (FDA) seeking emergency use authorization (EUA) for its BA.4/BA.5 Omicron-focused bivalent COVID-19 booster vaccine.
The candidate, or mRNA-1273.222, would be formulated as a... Read More »
Amid a monkeypox outbreak that continues to grow internationally, the Biomedical Advanced Research and Development Authority (BARDA) exercised an option on an existing contract this week to acquire additional intravenous (IV) doses of the TPOXX smallpox treatment.
TPOXX is a U.S. Food and Drug... Read More »
The Defense Advanced Research Projects Agency (DARPA) has advanced to the second phase of its No Manning Required Ship (NOMARS) program, selecting Serco Inc. for design elements.
The NOMARS initiative targets building and demonstrating a new medium unmanned surface vessel (MUSV) capable of going... Read More »
Bavarian Nordic reached an agreement last week with pharmaceutical contract manufacturer Grand River Aseptic Manufacturing (GRAM), making arrangements backed by the U.S. Department of Health and Human Services (HHS) to create the first U.S. fill and finish line for the JYNNEOS vaccine.
JYNNEOS... Read More »
Textron Aviation has delivered two Beechcraft King Air 260 aircraft to the U.S. Forest Service, with the aircraft manufacturing noting the aircraft would perform wildfire mapping missions.
“We are honored the U.S. Forest Service has added the King Air 260 to its fleet,” Textron Aviation... Read More »
Roche Diagnostics announced a new test for its line-up this week to offer additional means for decision-making and treatment options surrounding SARS-CoV-2, particularly in at-risk patient groups.
The Elecsys IGRA SARS-CoV-2 test focuses on the T-cell response to offer a potentially better... Read More »
Defense, aerospace, and security firm BAE Systems has secured an $88 million Marine Corps contract to build multiple ACV-30 Production Representative Test Vehicles (PRTVs).
“We are committed to equipping the Marine Corps with the best technology available to provide them with a decisive... Read More »
Responding to the ongoing monkeypox outbreak worldwide, the Biomedical Advanced Research and Development Authority (BARDA) last week exercised procurement options for SIGA Technologies, Inc.’s intravenous TPOXX treatments of smallpox.
Those treatments, valued at approximately $26 million,... Read More »
Pfizer Inc. and Valneva SE this week started a Phase 3 clinical study -- Vaccine Against Lyme for Outdoor Recreationists (VALOR) -- to study the efficacy, safety and immunogenicity of a Lyme disease vaccine candidate known as VLA15.
Currently, VLA15 is the only Lyme disease vaccine undergoing... Read More »
Curtiss-Wright Corporation officials said the firm has secured
contracts valued over $220 million from Bechtel Plant Machinery, Inc. (BPMI) and General Dynamics Electric Boat to aid the Navy's defense platforms.
“Curtiss-Wright is proud to have been awarded these important naval defense... Read More »
The U.S. Department of Defense (DoD) awarded a $127 million contract to defense, technologies, and shipbuilder company Huntington Ingalls Industries (HII) to improve systems integration through research, development, testing, and evaluation efforts.
Over five years, HII will work to improve the... Read More »
The Missile Defense Agency (MDA) has awarded Northrop Grumman Corporation an indefinite delivery, indefinite quantity contract for the Ground-based Midcourse Defense (GMD) Weapon System (GWS) program.
The agreement reflects a maximum amount of $3,286,745,005, noting the GWS program domestically... Read More »
The U.S. Department of Homeland Security (DHS) and Federal Emergency Management Agency (FEMA) recently announced the selections for $1.16 billion in climate resilience funding through two competitive grant programs to help communities across the nation enhance climate and disaster... Read More »
To improve first responder operations and get them the best technology, the Department of Homeland Security (DHS) Science and Technology Directorate (S&T) hosted the Urban Operational Experimentation (OpEx) 2022 from July 18-22, 2022.
At this gathering, S&T and its National Urban Security... Read More »
The Federal Law Enforcement Training Centers (FLETC) recently outlined the results of a recent school safety summit tailored for federal, state, local, tribal, territorial, and campus law enforcement personnel.
The School Safety Summit: Strategies for Prevention was conducted July 19-21, 2022,... Read More »
National Intellectual Property Rights Coordination Center (IPR Center) authorities recently detailed collaboration with 94 Interpol member countries resulting in 7,800 illicit medication seizures totaling $11 million.
Operation Pangea XV was conducted from June 23-30. The scope of work included... Read More »
The biopharmaceutical company Soligenix, Inc. signed a worldwide exclusive license this week guaranteeing supply of its ricin antigen to SERB Pharmaceuticals, which the latter intends to use in developing a therapeutic treatment for ricin toxin poisoning.
"We are pleased to be partnering with... Read More »
As concerns about the monkeypox outbreak worldwide continued to grow, the U.S. Department of Health and Human Services (HHS) responded last week with an order for another 2.5 million doses of Bavarian Nordic’s JYNNEOS monkeypox vaccine to fill the Strategic National Stockpile (SNS).
While the... Read More »
Beginning last week, Aegis Sciences began testing for monkeypox at its laboratories in Nashville, Tenn., adding potential capacity for up to 10,000 tests per week to the Center for Disease Control and Prevention’s (CDC) national Laboratory Response Network (LRN).
To achieve this, Aegis will... Read More »
Bolstering the number of options for use against SARS-CoV-2, the United States Food and Drug Administration (FDA) issued an emergency use authorization (EUA) this week for the Novavax COVID-19 Vaccine, Adjuvanted.
This authorization greenlit the vaccine for use on those at least 18 years old and... Read More »
The Defense Advanced Research Projects Agency (DARPA) recently detailed the successful execution of its first Operational Fires (OpFires) program flight test at White Sands Missile Range in New Mexico.
The OpFires system accomplished all test objectives, including the initial use of a U.S.... Read More »
Lockheed Martin officials are touting the initial delivery of the Multiple Launch Rocket System (MLRS) M270A2 launcher to the Army at the Precision Fires Center of Excellence in Camden, Ark.
"This delivery represents a significant milestone for Lockheed Martin, as the modernized system will... Read More »
Northrop Grumman Corporation recently touted the completion of a preliminary design review the firm said would result in a high-energy laser prototype for the U.S. Department of Defense (DoD).
In March 2021, Northrop Grumman secured a $72 million DoD pact via the High Energy Laser Scaling... Read More »
With new and aggressive strains of COVID-19 continuing to emerge, such as the omicron subvariants BA.4/5, Moderna, Inc. has continued developing new means to counter them, including its booster candidate mRNA-1273.214, which recently delivered promising results.
One month after administration... Read More »
On Friday, the U.S. Department of Health and Human Services (HHS) announced it had secured 3.2 million doses of the COVID-19 vaccine, Novavax.
Working in collaboration with the U.S. Department of Defense (DOD), HHS said it acquired the doses as a way to provide additional protection options for... Read More »
The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) recently awarded a $161,000 grant to Kenzen, Inc., based in Kansas City, Mo., to develop wearable technology to prevent heat-related injuries.
S&T’s Silicon Valley Innovation Program (SVIP) targeted... Read More »
States and jurisdictions will begin receiving another 144,000 doses of the Bavarian Nordic JYNNEOS vaccine from the Strategic National Stockpile (SNS) this week as the U.S. Department of Health and Human Services (HHS) pivots to focus more heavily on monkeypox.
As of July 8, the Centers for... Read More »
New recommendations meant to overhaul U.S. research oversight for enhanced potential pandemic pathogens (ePPPs) and life sciences dual-use efforts were submitted last week by a 34-member group of scientists, public health experts, and policy researchers.
These recommendations were submitted by... Read More »
Threat detection and security firm Smiths Detection announced that it has entered an agreement with Kromek to deliver wearable radiation detection equipment to North and South America.
“Smiths Detection is committed to deliver the best security screening solutions to our customers," Smiths... Read More »
More than 50 participants from 19 countries gathered in Belgium last month for the first in-person meeting of the International Partnership for Disarmament Verification (IPNDV) in more than two years to tackle a tabletop exercise for verifying the transport and long-term storage of nuclear... Read More »
The U.S. Chemical Security Analysis Center (CSAC) opened an experimental new facility known as the Chemical Security Laboratory (CSL) this week in partnership with the U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC).
Located at Aberdeen Proving Ground in... Read More »
Army Contracting Command – Detroit Arsenal has placed a $216 million order with Oshkosh Defense for 513 Joint Light Tactical Vehicles (JLTVs) and 1,152 (JLTV-T) trailers.
The vehicles and trailers would supply the U.S. Army, U.S. Marine Corps, U.S. Air Force, U.S. Navy, and the Armed Forces of... Read More »
Responding to the more than 450 cases of monkeypox reported in the United States as of July 1, the U.S. Department of Health and Human Services (HHS) ordered another 2.5 million doses of Bavarian Nordic’s JYNNEOS vaccine for smallpox and monkeypox.
The case count held at 459 at the end of... Read More »
In an effort to stock up for emergencies involving nerve agents, the Biomedical Advanced Research and Development Authority (BARDA) announced last week it will work with French developer Crossject to gain ZENEO needle-free autoinjectors for the anticonvulsant midazolam.
Midazolam works to treat... Read More »
The efforts of an interdisciplinary research team funded by the National Institutes of Health’s Rapid Acceleration of Diagnostics (RADx) Tech program have yielded a quick, cost-effective new means of detecting and identifying known variants and subvariants of SARS-CoV-2.
The results of the... Read More »
